The Future of Precision Medicine Symposium series was launched in 2021 with great success; we are now excited to announce the second edition: The Future of Precision Medicine Symposium – 2022. The Symposium marks major innovations in precision diabetes medicine from cutting-edge research through clinical implementation.
The discovery of insulin 100 years ago was a true breakthrough and lifesaver in the treatment of people with diabetes. However, despite being around for a century, insulin and other means of treatment, often deployed in a one-size-fits-all manner, still fail to take most people to a level of control that normalizes morbidity and mortality. Precision medicine, the tailoring of disease prevention, diagnosis and treatment strategies based on an individual’s genetics and other biomarkers, lifestyle and environment, does just that, by helping optimise medical decisions.
This two-day symposium on the Future of Precision Medicine will explore diverse aspects of precision diabetes medicine, featuring lectures and panel discussions on:
- The lived experience
- Trans-ethnic perspectives
- Clinical translation
- The role of AI
- The ADA/EASD Precision Diabetes Medicine Initiative
- Precision medicine: deal or no deal?
The symposium will also celebrate the winner of the EFSD and Novo Nordisk Foundation Precision Diabetes Medicine Award. The award honours innovative research in both clinical and basic science that is likely to minimise the future burden of diabetes and other chronic disease.
Confirmed speakers, panelists and facilitators:
- Professor Allan Vaag, Lund University (S)
- Professor Chantal Mathieu, KULeuven (BE)
- Person with diabetes Christian Collin (DK)
- Professor Elisabeth Selvin, Johns Hopkins University (US)
- Professor Gary Frost, Imperial College London (UK)
- Professor Guillaume Paré, McMaster University (CA)
- Professor K. Venkat Narayan, Emory University (US)
- Mother to a person with type 1-diabetes Maria Tørnes, Nurse specialist at Steno Diabetes Center Zealand (DK)
- Professor Robert Wagner, Heinrich Heine University Düsseldorf (DE)
- Shivani Misra, Imperial College London (UK)
- Professor Ruth Loos, Novo Nordisk Center for Basic Metabolic Research, Copenhagen University (DK)
- Person with diabetes Sophie Hindkjær (DK)
- Professor Ronald Ma, The Chinese University of Hong Kong (HK)
- Professor Thiusius Rajeeth Savarimuthu, University of Southern Denmark (DK)
- Professor Torben Hansen, Novo Nordisk Center for Basic Metabolic Research, University of Copenhagen (DK)
- Professor, M.D, Tina Vilsbøll, Steno Diabetes Center Copenhagen (DK)
- Director Dr. William T. Cefalu, National Institute of Diabetes and Digestive and Kidney Diseases (US)
Full programme will be announced in August.
Date/time: 17 November 9:00 AM – 18 November 3:30 PM
Registration is free and it will open in August. Sign up here if you want to receive an email, when the registration open.
Did you miss the The Future of Precision Medicine Symposium in 2021? Or do you want to get re-acquainted with the talks and discussions from last year? Click here